GenoMed Inc. (GMED)

[pioneertx]

From the website I now see 7 (assume paid) Employees.
A Scientific Advisory Board with 8 members
An Ethical, Legal and Social Implications committee with 5 members
A Business Development Advisory Board with 3 members

The various Committee/Board Members are:

Dr. Kilmer S. McCully

Dennis A. Robbins PhD, MPH (Founder, Integrated Decisions Ethics, Alternatives and Solutions, Phoenix AZ)

Joel V. Brill MD (Founder, Predictive Modelling, LLC, American Gastroenterological Association representative to the American Medical Association; expert in coding in reimbursement; Phoenix, AZ)

David Sundwall MD (head of American Clinical Laboratory Association, Washington, DC; former Director of the Indian Health Service)

Sylvia Johnson PhD (Director of Healthcare Research, UAW, Detroit, MI)

Sherry Dacso PhD, JD (healthcare lawyer with PhD in genetics, TX)

Scott Williams, Ph.D.,(Associate Professor in the Department of Medicine at Vanderbilt University, Nashville, Tennessee.)

Jason Moore, Ph.D.(Assistant Professor in the Program in Human Genetics at Vanderbilt University Medical School)

Masakazu Kobayashi, Ph.D.(Senior Vice President and Director of Research at Fujisawa Research Institute of America)

Frank Johnson MD(A leading academic surgeon with special expertise in cancer surgery. He is currently Professor of Surgery at St. Louis University School of Medicine, and Chief of Surgery at the St. Louis VA Medical Center.)

Geoffrey Boner M.B.B.Ch
(Dr. Boner was born in South Africa and graduated from Witwatersrand Medical School in 1960. Has been living in Israel ever since. He was registered as a Nephrologist in 1972, after completing training at the Sheba (Tel Hashomer) Medical Center and after a clinical fellowship in the Renal section of the Wisconsin University Hospital in Madison, Wisconsin. In 1969-76, he established a dialysis unit and clinical section in a peripheral hospital in Israel. From 1976-02, he worked in the Rabin Medical Center, affiliated with Tel Aviv University, initially as head of the Renal Failure Unit and since 1992 as head of the Institute of Hypertension and Kidney Diseases. He retired as an Associate Professor in 2002. He has written over 150 original articles, case reports and review articles. Dr. Boner has served as President of the Israel Society of Nephrology and Hypertension, Secretary of the Israel Society of Hypertension, Chairman of the Israeli examining board in Nephrology and at present is the Chairman of the subcommittee for renal transplantation at Israel Transplant. He was Secretary General of the 12th International Congress of Nephrology held in Jerusalem in 1993. His main interests at the moment are in mechanisms of progression of chronic renal disease, its prevention, and more especially diabetic nephropathy.)


Sergei Danilov, M.D., Ph.D., Dr.Sci.
(Dr. Danilov is one of the half-dozen or so world experts on the angiotensin I-converting enzyme (ACE). Between 1986 and 1993, while Deputy Director of the Cell Biology Department of the National Cardiology Research Center in Moscow, Russia, he developed over a dozen monoclonal antibodies against ACE. He used these antibodies to probe the role of ACE in normal physiology and disease. Dr. Danilov is the author of over 80 journal articles, of which 56 relate to ACE.)


David W. Moskowitz MD (GenoMed, Inc., St. Louis, MO)

-----------------------------------------------------------
-pioneertx